Incyte Corp. Stock
Price
Target price
€60.54
€60.54
0.870%
0.52
0.870%
€78.05
19.07.24 / Tradegate
WKN: 896133 / Symbol: INCY / Name: Incyte / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Incyte Corp. Stock
The Incyte Corp. stock is trending slightly upwards today, with an increase of €0.52 (0.870%) compared to yesterday's price.
With 12 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 78 € shows a positive potential of 28.84% compared to the current price of 60.54 € for Incyte Corp..
For the coming years our community has positive and negative things to say abot the Incyte Corp. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Customer and product portfolio" there were negative voices in the community.
Pros and Cons of Incyte Corp. in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Incyte Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Incyte Corp. | 0.870% | 3.735% | 2.367% | 5.031% | 6.697% | -9.723% | -15.411% |
| Regeneron Pharmaceuticals Inc. | -0.290% | -3.053% | -0.711% | 48.100% | 22.658% | 97.816% | 260.494% |
| Exact Sciences | -0.570% | 1.188% | 2.550% | -49.614% | -37.210% | -56.910% | -58.223% |
| Amgen Inc. | 0.150% | 0.412% | 5.746% | 44.360% | 16.884% | 46.795% | 89.569% |
Comments
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, down previously from $52.00.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its price target lowered by analysts at TD Cowen from $88.00 to $80.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INCY provided by MarketBeat
Incyte Co. (NASDAQ: INCY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $83.00 price target on the stock, down previously from $84.00.
Show more
Ratings data for INCY provided by MarketBeat